April 29, 2026 D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types
April 29, 2026 OP Bancorp Reports First Quarter 2026 Net Income of $7.2 Million, Diluted EPS of $0.48
